What is Acadia Pharmaceuticals Inc.'s Market Cap?

Acadia Pharmaceuticals Inc.'s Market Cap is $4.8B, based on as-reported figures from SEC (XBRL) filings.

What is Acadia Pharmaceuticals Inc.'s Enterprise Value?

Acadia Pharmaceuticals Inc.'s Enterprise Value is $4.4B, based on as-reported figures from SEC (XBRL) filings.

What is Acadia Pharmaceuticals Inc.'s Trailing P/E?

Acadia Pharmaceuticals Inc.'s Trailing P/E is 12.5×, based on as-reported figures from SEC (XBRL) filings.

What is Acadia Pharmaceuticals Inc.'s Price / Sales?

Acadia Pharmaceuticals Inc.'s Price / Sales is 4.2×, based on as-reported figures from SEC (XBRL) filings.

What is Acadia Pharmaceuticals Inc.'s EV / Revenue?

Acadia Pharmaceuticals Inc.'s EV / Revenue is 3.8×, based on as-reported figures from SEC (XBRL) filings.

What is Acadia Pharmaceuticals Inc.'s EV / EBITDA?

Acadia Pharmaceuticals Inc.'s EV / EBITDA is 45.2×, based on as-reported figures from SEC (XBRL) filings.

What is Acadia Pharmaceuticals Inc.'s Revenue (TTM)?

Acadia Pharmaceuticals Inc.'s Revenue (TTM) is $1.1B, based on as-reported figures from SEC (XBRL) filings.

What is Acadia Pharmaceuticals Inc.'s Net Income (TTM)?

Acadia Pharmaceuticals Inc.'s Net Income (TTM) is $380.5M, based on as-reported figures from SEC (XBRL) filings.

What is Acadia Pharmaceuticals Inc.'s EBITDA?

Acadia Pharmaceuticals Inc.'s EBITDA is $98.4M, based on as-reported figures from SEC (XBRL) filings.

What is Acadia Pharmaceuticals Inc.'s Diluted EPS (TTM)?

Acadia Pharmaceuticals Inc.'s Diluted EPS (TTM) is 2.21, based on as-reported figures from SEC (XBRL) filings.

Acadia Pharmaceuticals Inc. (ACAD) Financial Statements

Acadia Pharmaceuticals Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SB06N3

XNAS · usd

27.58▼ 0.44 (-1.57%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close28.02

Day's Range27.10 – 28.09

52-Week Range19.69 – 30.96

Volume1.5M

Avg Volume1.6M

Share Statistics

Shares Outstanding

Employees798

ExchangeXNAS

Listed2004-05-27

Share count as of July 28, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Acadia Pharmaceuticals Inc. (ACAD)

What is Acadia Pharmaceuticals Inc.'s Market Cap?: Acadia Pharmaceuticals Inc.'s Market Cap is $4.8B, based on as-reported figures from SEC (XBRL) filings.
What is Acadia Pharmaceuticals Inc.'s Enterprise Value?: Acadia Pharmaceuticals Inc.'s Enterprise Value is $4.4B, based on as-reported figures from SEC (XBRL) filings.
What is Acadia Pharmaceuticals Inc.'s Trailing P/E?: Acadia Pharmaceuticals Inc.'s Trailing P/E is 12.5×, based on as-reported figures from SEC (XBRL) filings.
What is Acadia Pharmaceuticals Inc.'s Price / Sales?: Acadia Pharmaceuticals Inc.'s Price / Sales is 4.2×, based on as-reported figures from SEC (XBRL) filings.
What is Acadia Pharmaceuticals Inc.'s EV / Revenue?: Acadia Pharmaceuticals Inc.'s EV / Revenue is 3.8×, based on as-reported figures from SEC (XBRL) filings.
What is Acadia Pharmaceuticals Inc.'s EV / EBITDA?: Acadia Pharmaceuticals Inc.'s EV / EBITDA is 45.2×, based on as-reported figures from SEC (XBRL) filings.
What is Acadia Pharmaceuticals Inc.'s Revenue (TTM)?: Acadia Pharmaceuticals Inc.'s Revenue (TTM) is $1.1B, based on as-reported figures from SEC (XBRL) filings.
What is Acadia Pharmaceuticals Inc.'s Net Income (TTM)?: Acadia Pharmaceuticals Inc.'s Net Income (TTM) is $380.5M, based on as-reported figures from SEC (XBRL) filings.
What is Acadia Pharmaceuticals Inc.'s EBITDA?: Acadia Pharmaceuticals Inc.'s EBITDA is $98.4M, based on as-reported figures from SEC (XBRL) filings.
What is Acadia Pharmaceuticals Inc.'s Diluted EPS (TTM)?: Acadia Pharmaceuticals Inc.'s Diluted EPS (TTM) is 2.21, based on as-reported figures from SEC (XBRL) filings.